3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

BMJ. 2012 Apr 3:344:e1782. doi: 10.1136/bmj.e1782.
No abstract available

MeSH terms

  • Anti-Bacterial Agents*
  • Cooperative Behavior
  • Drug Industry
  • Humans
  • Research*
  • Risk

Substances

  • Anti-Bacterial Agents